Abstract:Overexpression of cyclooxygenase 2 (COX-2) is frequently found in early and advanced lung cancers. However, the precise regulatory mechanism of COX-2 in lung cancers remains unclear. Here we identified cleavage and polyadenylation specific factor 4 (CPSF4) as a new regulatory factor for COX-2 and demonstrated the role of the CPSF4/COX-2 signaling pathway in the regulation of lung cancer growth and progression. Overexpression or knockdown of CPSF4 up-regulated or suppressed the expression of COX-2 at mRNA and protein levels, and promoted or inhibited cell proliferation, migration and invasion in lung cancer cells. Inhibition or induction of COX-2 reversed the CPSF4-mediated regulation of lung cancer cell growth. Cancer cells with CPSF4 overexpression or knockdown exhibited increased or decreased expression of p-IKKα/β and p-IκBα, the translocation of p50/p65 from the cytoplasm to the nucleus, and the binding of p65 on COX-2 promoter region. In addition, CPSF4 was found to bind to COX-2 promoter sequences directly and activate the transcription of COX-2. Silencing of NF-κB expression or blockade of NF-κB activity abrogated the binding of CPSF4 on COX-2 promoter, and thereby attenuated the CPSF4-mediated up-regulation of COX-2. Moreover, CPSF4 was found to promote lung tumor growth and progression by up-regulating COX-2 expression in a xenograft lung cancer mouse model. CPSF4 overexpression or knockdown promoted or inhibited tumor growth in mice, while such regulation of tumor growth mediated by CPSF4 could be rescued through the inhibition or activation of COX-2 signaling. Correspondingly, CPSF4 overexpression or knockdown also elevated or attenuated COX-2 expression in tumor tissues of mice, while treatment with a COX-2 inducer LPS or a NF-κB inhibitor reversed this elevation or attenuation. Furthermore, we showed that CPSF4 was positively correlated with COX-2 levels in tumor tissues of lung cancer patients. Simultaneous high expression of CPSF4 and COX-2 proteins predicted poor prognosis of patients with lung cancers. Our results therefore demonstrated a novel mechanism for the transcriptional regulation of COX-2 by CPSF4 in lung cancer, and also offer a potential therapeutic target for lung cancers bearing aberrant activation of CPSF4/COX-2 signaling.

Fibroblasts mediate the angiogenesis of pheochromocytoma by increasing COX4I2 expression

HIF1A transcriptional regulation of COX4I2 impacts angiogenesis in pheochromocytoma

Figure S1-4 from COX-2/PGE2 Axis Regulates HIF2α Activity to Promote Hepatocellular Carcinoma Hypoxic Response and Reduce the Sensitivity of Sorafenib Treatment

[Study of COX-2 Expression and Angiogenesis in Non-Small Cell Lung Cancer].

Cleavage and Polyadenylation Specific Factor 4 Targets NF-κB/cyclooxygenase-2 Signaling to Promote Lung Cancer Growth and Progression

Cyclooxygenase-2 expression correlates with angiogenesis and vascular endothelial growth factor-A in non-small cell lung cancer

COX4I2 is a Novel Biomarker of Blood Supply in Adrenal Tumors.

The function and mechanism of COX-2 in angiogenesis of gastric cancer cells

Therapeutic Efficacy of ECs Foxp1 Targeting Hif1α-Hk2 Α-Hk2 Glycolysis Signal to Restrict Angiogenesis

From clinic to mechanism: Proteomics-based assessment of angiogenesis in adrenal pheochromocytoma.

Therapeutic Efficacy of ECs Foxp1 Targeting Hif1α-Hk2 Glycolysis Signal to Restrict Angiogenesis

Involvement of COX-2 in VEGF-induced angiogenesis via P38 and JNK pathways in vascular endothelial cells.

COX-2 expression and tumor angiogenesis in colorectal cancer.

Cyclooxygenase-2 promotes tumor growth and suppresses tumor immunity.

Cyclooxygenase-2 Induces Angiogenesis in Pancreatic Cancer Mediated by Prostaglandin E-2

Potential Involvement of the Cyclooxygenase-2 Pathway in Hepatocellular Carcinoma-Associated Angiogenesis

Relationship of Heparanase-1 and Cox-2 Expressions with Angiogenesis in Pheochromocytoma

Cyclooxygenase-2-dependent Expression of Angiogenic CXC Chemokines ENA-78/CXC Ligand (CXCL) 5 and Interleukin-8/Cxcl8 in Human Non-Small Cell Lung Cancer.

Hypoxia-induced P4HA1 overexpression promotes post-ischemic angiogenesis by enhancing endothelial glycolysis through downregulating FBP1

Fibroblast CEBPD/SDF4 Axis in Response to Chemotherapy-Induced Angiogenesis Through CXCR4

High COX‐2 Expression in Cancer‐associated Fibiroblasts Contributes to Poor Survival and Promotes Migration and Invasiveness in Nasopharyngeal Carcinoma